It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.

This site is intended for patients in the UK who have been prescribed Entresto® (sacubitril/valsartan). This website has been developed and funded by Novartis Pharmaceuticals UK Ltd.

Never stop taking your medication without first consulting your healthcare professional

When taking Entresto®, you may well experience side effects for example light-headedness and dizziness, which could make you feel as though the treatment is not good for you. Stopping your Entresto treatment may cause your heart condition to get worse. You should seek medical advice before you make the decision to stop taking it, even if you are feeling better.

Watch how Entresto® (sacubitril/valsartan) works

This mode of action video demonstrates sacubitril/valsartan’s impact on your heart failure. Watch now to learn more about the effects.

Treating heart failure with  sacubitril/valsartan

Interact with this tool to see the impact of heart failure on the overall health of the heart.

button

UK | May 2022 | 197476

YOURCHOICE
ENGAGE

laptop icon

Supporting you at every stage of your treatment journey

The Entresto® YOURCHOICE ENGAGE programme provides patients like you with valuable support on your treatment journey. Through regular emails we can support you in learning more about your Entresto® treatment, understand how to manage any possible side effects and even help you to find further helpful information and resources.

YOURCHOICE ENGAGE can also help you to:

  • Find reliable and up-to-date information relevant to you

  • Read and hear stories from other patients

  • Learn tips to help you stay on track with your treatment

  • Discover information and sources of emotional and well-being support

LEARN MORE

UK | May 2023 | 172746-2

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You should also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk. By reporting side effects you can help provide more information on the safety of this medicine.

Novartis Pharmaceuticals UK Limited is a limited liability company registered in England and Wales under number 119006. Registered office: The WestWorks Building, White City Place, 195 Wood Lane, London, W12 7FQ.

Use of this website is governed by our terms of use and privacy policy. Click here to review and change your cookie settings. Accessibility. 

UK | May 2023 | 262485

My Entresto

© 2023 Novartis Pharmaceuticals UK Ltd. All rights reserved.
This site is intended for an audience in the UK.

Novartis